05 June 2012
Ovary involvement of diffuse large B-cell lymphoma
Rong Hu, Miao Miao, Rong Zhang, Yingchun Li, Jia Li, Ke Zhu, Ying Yang, Zhuogang Liu, Wei YangDOI: 10.12659/AJCR.882997
Am J Case Rep 2012; 13:96-98
Abstract
Background: Primary ovarian non-Hodgkin’s lymphoma (PONHL) is an uncommon entity; its pathology is usually diffuse large B cell lymphoma (DLBCL).
Case Reports: We report 3 cases of ovary involvement of DLBCL, 1 of which rapidly developed to central nervous system involvement. Diagnosis and subsequent treatment are discussed and the literature on the origin, epidemiology, clinical presentation, diagnosis, treatment and prognosis of ovary lymphoma are reviewed. All patients were diagnosed as having DLBCL after ovary biopsy, and were subsequently given regular chemotherapy. Two of them obtained remission and 1 of them had central nervous system involvement.
Conclusions: Ovary involvement of DLBCL is rare; prognosis is related to the overall clinical manifestation and some serum biomarkers. Diagnosis is established by ovary biopsy. Inaccurate or delayed diagnosis is often due to the lesions presenting as a mass resembling ovary cancer and may lead to poor outcome. Treatment regimen mainly consists of chemotherapy (CHOP) associated with rituximab. Intrathecal chemotherapy may play an important role in prevention of central nervous system involvement.
Keywords: DLBCL-lymphoma, central nervous system (CNS), intrathecal chemotherapy
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.948238
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947782
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947794
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947096
Most Viewed Current Articles
21 Jun 2024 : Case report
100,489
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
53,790
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
36,376
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
07 Jul 2023 : Case report
25,034
DOI :10.12659/AJCR.940200
Am J Case Rep 2023; 24:e940200